Standard BioTools Price to Sales Ratio 2010-2024 | LAB
Historical PS ratio values for Standard BioTools (LAB) over the last 10 years. The current P/S ratio for Standard BioTools as of April 30, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Standard BioTools P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-04-30 | 1.11 | 2.18 | |
| 2024-12-31 | 1.75 | $0.51 | 3.44 |
| 2024-09-30 | 1.93 | $0.73 | 2.64 |
| 2024-06-30 | 1.77 | $0.93 | 1.90 |
| 2024-03-31 | 2.71 | $1.18 | 2.29 |
| 2023-12-31 | 2.21 | $1.35 | 1.64 |
| 2023-09-30 | 2.90 | $1.33 | 2.17 |
| 2023-06-30 | 1.93 | $1.34 | 1.44 |
| 2023-03-31 | 1.95 | $1.23 | 1.59 |
| 2022-12-31 | 1.17 | $1.26 | 0.93 |
| 2022-09-30 | 1.10 | $1.42 | 0.78 |
| 2022-06-30 | 1.60 | $1.46 | 1.09 |
| 2022-03-31 | 3.59 | $1.63 | 2.20 |
| 2021-12-31 | 3.92 | $1.73 | 2.27 |
| 2021-09-30 | 6.59 | $1.84 | 3.58 |
| 2021-06-30 | 6.16 | $2.02 | 3.05 |
| 2021-03-31 | 4.52 | $1.98 | 2.29 |
| 2020-12-31 | 6.00 | $1.93 | 3.11 |
| 2020-09-30 | 7.43 | $1.80 | 4.14 |
| 2020-06-30 | 4.01 | $1.63 | 2.47 |
| 2020-03-31 | 2.54 | $1.67 | 1.52 |
| 2019-12-31 | 3.48 | $1.79 | 1.94 |
| 2019-09-30 | 4.63 | $2.12 | 2.18 |
| 2019-06-30 | 12.32 | $2.48 | 4.97 |
| 2019-03-31 | 13.29 | $2.75 | 4.84 |
| 2018-12-31 | 8.62 | $2.88 | 2.99 |
| 2018-09-30 | 7.49 | $2.91 | 2.58 |
| 2018-06-30 | 5.96 | $2.89 | 2.07 |
| 2018-03-31 | 5.84 | $3.02 | 1.93 |
| 2017-12-31 | 5.89 | $3.25 | 1.81 |
| 2017-09-30 | 5.04 | $3.27 | 1.54 |
| 2017-06-30 | 4.04 | $3.32 | 1.22 |
| 2017-03-31 | 5.69 | $3.47 | 1.64 |
| 2016-12-31 | 7.28 | $3.61 | 2.02 |
| 2016-09-30 | 8.01 | $3.81 | 2.10 |
| 2016-06-30 | 9.03 | $4.04 | 2.23 |
| 2016-03-31 | 8.07 | $4.06 | 1.99 |
| 2015-12-31 | 10.81 | $4.00 | 2.70 |
| 2015-09-30 | 8.11 | $4.13 | 1.96 |
| 2015-06-30 | 24.20 | $4.19 | 5.77 |
| 2015-03-31 | 42.10 | $4.19 | 10.05 |
| 2014-12-31 | 33.73 | $4.20 | 8.02 |
| 2014-09-30 | 24.50 | $3.82 | 6.42 |
| 2014-06-30 | 29.40 | $3.48 | 8.45 |
| 2014-03-31 | 44.07 | $3.18 | 13.86 |
| 2013-12-31 | 38.28 | $2.80 | 13.68 |
| 2013-09-30 | 21.94 | $2.69 | 8.17 |
| 2013-06-30 | 17.46 | $2.54 | 6.88 |
| 2013-03-31 | 18.51 | $2.48 | 7.46 |
| 2012-12-31 | 14.31 | $2.44 | 5.86 |
| 2012-09-30 | 17.00 | $2.46 | 6.90 |
| 2012-06-30 | 15.04 | $2.42 | 6.21 |
| 2012-03-31 | 15.73 | $2.32 | 6.77 |
| 2011-12-31 | 13.16 | $2.59 | 5.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.440B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
| Tempus AI (TEM) | United States | $9.349B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
| Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
| IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
| Privia Health (PRVA) | United States | $2.840B | 212.82 |
| Enovis (ENOV) | United States | $1.994B | 12.34 |
| Schrodinger (SDGR) | United States | $1.883B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.471B | 31.72 |
| Phreesia (PHR) | United States | $1.461B | 0.00 |
| Azenta (AZTA) | United States | $1.216B | 56.62 |
| 10x Genomics (TXG) | United States | $1.025B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Talkspace (TALK) | United States | $0.532B | 316.00 |
| Veradigm (MDRX) | United States | $0.457B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.373B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Pulmonx (LUNG) | United States | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.31 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |